SCHEMBL1155640

SCHEMBL1155640

CC=COCCOCCOCCO

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TSHR P16473 2/20 0.48
MAPK1 P28482 1/20 0.48
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1155428 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL5974292 1.00 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL28620738 0.87
SCHEMBL1476660 0.87
SCHEMBL1476838 0.87
SCHEMBL28616303 0.87
SCHEMBL1476172 0.87
SCHEMBL3036185 0.85 TSHR (0.35) MEN1KMT2ATSHRMAPK1ALDH1A1
SCHEMBL666077 0.85
SCHEMBL15836162 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711849-A1 ADDITIVES FOR PREVENTING BUBBLE FORMATION DURING 3D PRINTING ARKEMA FRANCE (FR) 2026-03-18 EP disclosed
US-20260022261-A1 SECURITY INK COMPOSITION AND MACHINE-READABLE SECURITY FEATURE DERIVED THEREFROM SICPA HOLDING SA (CH) 2026-01-22 US disclosed
US-12421011-B2 Coatings and articles with light-blocking properties SIEGWERK DRUCKFARBEN AG & CO. KGAA (DE) 2025-09-23 US disclosed
EP-4577414-A1 SECURITY INK COMPOSITION AND MACHINE-READABLE SECURITY FEATURE DERIVED THEREFROM Sicpa Holding SA (CH) 2025-07-02 EP disclosed
EP-4563614-A1 CURABLE COMPOSITION COMPRISING A MULTIFUNCTIONAL HALOGENATED THIOXANTHONE AND ITS USES ARKEMA FRANCE (FR) 2025-06-04 EP disclosed
EP-2890847-B1 OPTICALLY VARIABLE SECURITY THREADS AND STRIPES SICPA HOLDING SA (CH) 2025-05-14 EP disclosed
US-20250101146-A1 OXYETHYLENE CHAIN-CONTAINING POLYMER MARUZEN PETROCHEMICAL CO., LTD. (JP) 2025-03-27 US disclosed
EP-4527859-A1 OXYETHYLENE CHAIN-CONTAINING POLYMER Maruzen Petrochemical Co., Ltd. (JP) 2025-03-26 EP disclosed
EP-4527886-A1 CELL-ADHESIVE COMPOSITION AND POLYMER-COATED MICROPARTICLES Maruzen Petrochemical Co., Ltd. (JP) 2025-03-26 EP disclosed
US-20250064749-A1 CELL-ADHESIVE COMPOSITION AND POLYMER-COATED MICROPARTICLES MARUZEN PETROCHEMICAL CO., LTD. (JP) 2025-02-27 US disclosed
US-6706777-B1 CAN BE CURED IN THE ABSENCE OF A PHOTOINITIATOR WITH A IRRADIATION SOURCE OF PRACTICAL INTENSITY AND ENERGY VALUE SUN CHEMICAL CORPORATION 2004-03-16 US disclosed
WO-2003089479-A2 CURING OF COATINGS INDUCED BY PLASMA CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-10-30 WO disclosed
EP-0878482-B1 An active energy ray curable composition comprised of a maleimide derivative and a method for curing the said curable composition DAINIPPON INK & CHEMICALS (JP) 2003-03-26 EP disclosed
US-6410611-B1 COATINGS, SURFACE FINISHES, BINDERS DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-06-25 US disclosed
US-6376702-B1 A 1-ALKENYL ETHER SHOWA DENKO K.K. (JP) 2002-04-23 US disclosed
US-20010036591-A1 Iodonium salts as latent acid donors IGM GROUP B.V. (NL) 2001-11-01 US disclosed
US-6306555-B1 RADIATION-SENSITIVE COMPOSITION COMPRISING CATIONICALLY OR ACID-CATALYTICALLY POLYMERISABLE OR CROSSLINKABLE COMPOUND OR COMPOUND THAT INCREASES ITS SOLUBILITY IN DEVELOPER UNDER ACTION OF ACID, AND AT LEAST ONE DIARYLIODONIUM SALT CIBA SPECIALTY CHEMICALS CORP. 2001-10-23 US disclosed
US-6204410-B1 FOR FREE RADICAL POLYMERIZATION SHOWA DENKO KABUSHIKI KAISHA (JP) 2001-03-20 US disclosed
EP-0957079-A1 NEW ETHER COMPOUNDS AND PROCESS FOR PRODUCING THE SAME Showa Denko Kabushiki Kaisha (JP) 1999-11-17 EP disclosed
EP-0878482-A1 An active energy ray curable composition comprised of a maleimide derivative and a method for curing the said curable composition DAINIPPON INK AND CHEMICALS, INC. (JP) 1998-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250064749-A1 CELL-ADHESIVE COMPOSITION AND POLYMER-COATED MICROPARTICLES EPCAM, ICAM1, H1-10 MEN1 891/4885KMT2A 3700/4885TSHR 1861/4885
US-20260022261-A1 SECURITY INK COMPOSITION AND MACHINE-READABLE SECURITY FEATURE DERIVED THEREFROM FGR, LBR, AIFM2 MEN1 1400/4885KMT2A 3234/4885TSHR 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.